
Sunday, June 01, 2025 5:45:20 PM
Recent RNAZ News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2025 08:15:23 PM
- TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board • PR Newswire (US) • 05/28/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:15:55 PM
- TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported • PR Newswire (US) • 05/08/2025 12:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 08:45:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2025 09:20:27 PM
- TransCode Therapeutics Announces Effective Date for 1-for-28 Reverse Stock Split • PR Newswire (US) • 05/05/2025 09:07:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2025 08:20:28 PM
- TransCode Therapeutics Announces 1-for-28 Reverse Stock Split • PR Newswire (US) • 05/02/2025 08:10:00 PM
- TransCode Therapeutics Reports Further Progress on Phase 1a Clinical Trial with No Dose Limiting Toxicities Reported in Patients with Metastatic Cancer • PR Newswire (US) • 05/01/2025 01:01:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/30/2025 08:17:52 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/21/2025 08:41:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/21/2025 08:40:23 PM
- TransCode Therapeutics, Inc. Announces Adjournment of Special Meeting and Information for Adjourned Special Meeting • PR Newswire (US) • 04/21/2025 08:37:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/16/2025 11:40:11 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 04/15/2025 08:38:25 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/02/2025 08:58:30 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2025 08:15:44 PM
- TransCode Therapeutics Announces Initial Dosing in Fourth Cohort of Phase 1 Clinical Trial with TTX-MC138 • PR Newswire (US) • 03/27/2025 08:37:00 PM
- TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering • PR Newswire (US) • 03/25/2025 10:24:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2025 12:15:54 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/25/2025 11:00:52 AM
- TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • PR Newswire (US) • 03/24/2025 03:11:00 AM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 03/20/2025 09:16:50 PM
- TransCode Therapeutics Announces Safety Review Committee Approval to Open Fourth Cohort in Phase I/II Clinical Trial • PR Newswire (US) • 03/13/2025 11:47:00 AM
FEATURED Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM
VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM
Patented, Groundbreaking Blockchain for Public Companies 'BlackStar Digital Trading PlatformTM' can Facilitate U.S. Registered Securities to Trade on Blockchain Without Tokens. • BEGI • Jul 1, 2025 12:54 PM
UC Asset (UCASU) Public Offering's Acquisition Target Reported Better Results • UCASU • Jul 1, 2025 9:15 AM